To: Bill F. who wrote (74248 ) 1/22/2000 2:29:00 AM From: Skeeter Bug Respond to of 132070
a little financial commentary... see bottom of "report" earnings estimates go from 91 cents to 96 cents (6%) yet the stock price "target" goes from $45 to $65 (45%). say what? only in a bubble... >>Salomon Smith Barney January 19, 2000 SUMMARY: * Xilinx reported EPS of $0.20. Excluding better minority interest income, EPS were in-line with Street consensus and our $0.19 estimate. * Sales of $264.3 million rose 10.7% sequentially and 54% from a year ago, slightly better than our 10% sequential estimate. * Xilinx reported solid results for the December quarter. Although the company acknowledged some inventory issues at selected customer accounts, overall results were in-line with expectations. Order trends and design win activity provide a very upbeat outlook for calendar 2000. Xilinx management maintained sales guidance for the March 2000 quarter and raised expectations for fiscal 2001. * Bookings increased; raising estimates. Backlog and bookings rose in the quarter, and 'turns' business (i.e., orders that were received and shipped within the quarter) accounted for 50% of sales. The company expects a similar 'turns' hurdle for the March quarter, which is respectably toward the low end of the historical 50-60% range (i.e., low turns denotes better visibility). Management accordingly maintained its sequential growth guidance of 7% for March, which was what most analysts had modeled and slightly better than our earlier 6% assumption. As a result, we are raising our March quarter EPS estimate slightly from $0.20 to $0.21, and fiscal 2000 (March-ending) from $0.71 to $0.72. Management also indicated that sales growth in the 35-40% range was likely for fiscal 2001, significantly better than our earlier assumption of 30%. We believe this optimism is warranted given the strength of the PLD market and Xilinx's leadership position. As a result, we are raising our fiscal 2001 EPS estimate from $0.91 to $0.96. Our calendar 2000 EPS estimate is increased from $0.87 to $0.91, and calendar 2001 from $1.05 to $1.12. * Based on stronger revenue assumptions, we are raising our EPS estimate for fiscal 2001 from $0.91 to $0.96. We are boosting our price target from $45 to $65. <<